StockData
Century Therapeutics, Inc. logo

Century Therapeutics, Inc. (IPSC) stock

IPSCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.65+0.02 (+1.23%)

Close on Nov 13, 2026Market cap $298.77MP/E –Yield –

Century Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Century Therapeutics's market cap was $314.15M on Nov 11, 2026, against $47.18M a year earlier. Over the last 5 years it ranged from $40.86M to $866.61M, with a median of $190.87M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$314.15M+265.0%
2025Dec 31, 2025$86.08M+0.8%
2024Dec 31, 2024$85.40M-56.8%
2023Dec 29, 2023$197.59M-33.8%
2022Dec 30, 2022$298.49M-65.6%
2021Dec 31, 2021$866.61M–

More Century Therapeutics figures

See a number that looks wrong?